Beauty treatments based on photoactive extracts of microalgae

By using microalgae photoactive extracts and combining light activation technology, the problem of existing cosmetic methods failing to make full use of microalgae photoactive is solved, and ROS production and collagen synthesis are achieved significantly enhancement, skin elasticity and wrinkles are improved, providing Effective anti-aging and anti-wrinkle effects.

CN113811289BActive Publication Date: 2024-11-05LABES DANJOU +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080031490.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-05-02
Filing Date
2020-05-04
Publication Date
2024-11-05
Estimated Expiration
2040-05-04

AI Technical Summary

Technical Problem

The existing anti-aging and anti-wrinkle beauty methods fail to effectively utilize the photoactivity of microalgae, resulting in the inadequate activation of its antioxidant properties, which cannot significantly enhance the oxidative state of epidermal cells and collagen synthesis, and thus cannot effectively improve skin elasticity and wrinkle problems. .

Method used

Compositions containing microalgae photoactive extracts and activated by light irradiation in the range of 400 to 750 nm, increasing reactive oxygen derivatives (ROS) production and nitric oxide-dependent doses, thereby enhancing collagen synthesis and reducing promotion Release of inflammation cytokines and metalloproteinases promotes skin healing and cell regeneration.

Benefits of technology

Significantly improves skin elasticity, reduces wrinkles, enhances collagen production, promotes skin healing and cell regeneration, and provides anti-aging and anti-wrinkle effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0003321203440000011
    Figure HDA0003321203440000011
  • Figure HDA0003321203440000021
    Figure HDA0003321203440000021
  • Figure HDA0003321203440000031
    Figure HDA0003321203440000031
Patent Text Reader

Abstract

This invention relates to a skin cosmetic care method comprising the steps of: applying a cosmetic composition containing a photoactive extract of at least one microalgae to the skin, and illuminating the area where the composition has been applied. The invention also includes an apparatus for performing cosmetic care according to the method, and a kit comprising a cosmetic composition according to the invention and an illumination device, the cosmetic composition containing a photoactive extract of at least one microalgae. Finally, the invention includes the use of the apparatus according to the invention for anti-aging and / or anti-wrinkle treatments and / or treatments promoting healing of the skin area.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to a method for cosmetic skin care comprising the steps of applying to the skin a composition comprising at least one photoactive extract of microalgae and irradiating the area to which the composition has been applied. The present invention also comprises a lighting device for cosmetic treatment according to the method, and a kit comprising a cosmetic composition according to the invention comprising at least one photoactive extract of microalgae and a lighting device. The present invention finally comprises the use of a device according to the invention for anti-aging and / or anti-wrinkle treatment and / or treatment to promote healing of the skin area.

[0002] Maintaining a youthful appearance is a constant concern today. Over time, and especially in the case of chronological and / or photoaging, the skin undergoes numerous changes and degenerations, which lead, at the tissue level, to structural disruptions of the epidermis, the dermal-epidermal junction, the dermis, and the blood supply and innervation system, as well as to slowing down or dysfunction of various cellular metabolisms, such as those involved in the balance of barrier functions or in the production of melanin. At the cellular level, aging leads to physiological or metabolic changes in the main cell types, such as fibroblasts of the dermis, keratinocytes of the epidermis, and melanocytes.

[0003] Skin aging is caused by two separate and independent processes that involve endogenous and exogenous factors. Endogenous aging or chronobiological aging corresponds to normal age-related aging or physiological aging.

[0004] Intrinsic aging in particular slows down the regeneration of epidermal cells and causes fine lines or wrinkles. At the dermal level, the biosynthesis of macromolecules such as collagen decreases with age, changing the mechanical properties of the dermis and causing the skin to sag, which is one of the clinical symptoms of aging.

[0005] Extrinsic aging corresponds to aging that is generally caused by the external environment and in particular to photoaging due to sunlight exposure. Light-induced skin aging, i.e. aging caused by sunlight exposure, is also called photoaging or solar dermatopathy. Photoaging is the result of the degradation of collagen fibers in the dermis and leads in particular to clinical skin changes such as coarse wrinkles and the formation of softened and weather-exposed skin. Thus, long-term exposure to UV rays accelerates the aging of the skin. Extrinsic aging can also be caused by smoking, a diet high in fat or, indeed, by the consumption of alcohol. These factors influence in particular the gradual change of the redox environment towards a pro-oxidative state, leading to a progressive change in endothelial factors that causes endothelial dysfunction.

[0006] There is thus a large number of so-called "anti-aging" cosmetic care methods, which aim to prevent and / or treat aging, in particular photoaging and its signs, in particular to prevent the appearance of wrinkles and to significantly reduce existing wrinkles, and also to reduce or inhibit age spots. For example, these cosmetic care methods consist in the regular application of so-called "anti-aging" or "anti-wrinkle" lotions or creams, which contain various cosmetic active ingredients.

[0007] In a similar way to aging, especially after injury or surgery, the skin becomes fragile, so the body begins a healing process that allows the tissue to repair. This process requires a variety of cell types so that bleeding can be prevented, the body can be protected, the tissue to be repaired can be cleansed, and ultimately the wound can be closed.

[0008] Today there is a large number of cosmetic treatments that promote healing, mainly in the form of creams or lotions and containing various cosmetic active ingredients.

[0009] Among these anti-aging, anti-wrinkle and / or healing cosmetic active ingredients, microalgae appear to be a rich source of lipids, proteins, polysaccharides, vitamins (B1, B6, B12, C, E, K, etc.), pigments and antioxidants, the latter also acting as antioxidants. These pigments include carotenoids, phycobiliproteins (phycoerythrin and phycocyanin), phycocyanin, phycoerythrin, astaxanthin or indeed beta-carotene.

[0010] Therefore, various cosmetic compositions use extracts of microalgae as anti-aging and anti-wrinkle ingredients. In particular, patent application CN104224608, which describes an anti-aging and anti-wrinkle emulsion comprising an extract of Spirulina, patent application US2005 / 0220810, which describes an anti-aging and anti-wrinkle composition comprising an extract of Chlorella, or indeed application JP2007176832, which describes an anti-aging composition comprising an extract of Aphanizomenon.

[0011] In a similar manner, one may cite patent US Pat. No. 7,285,266, which describes a cosmetic composition comprising an extract of Thalassiosira fluviatilis or Thalassiosira weissflogii.

[0012] Among all their benefits, extracts of these microalgae can especially reduce oxidative stress in epidermal cells thanks to their antioxidant properties.

[0013] Contrary to the traditional antioxidant effects sought by those skilled in the art in microalgae, the applicant has developed anti-aging and anti-wrinkle cosmetic compositions, and / or cosmetic compositions promoting skin healing, as the main cosmetic active ingredient, comprising microalgae. The oxidative activity of the microalgae is significantly enhanced by combining the application of light, thereby activating the production of reactive oxygen derivatives (ROS).

[0014] In fact, instead of using the natural antioxidant properties of microalgae, the Applicant has developed a method that allows the use of light to activate microalgae, thereby increasing the production of reactive oxygen derivatives (ROS) in said microalgae and enhancing the oxidative state of epidermal cells, as well as increasing the dose-dependent nitric oxide, thereby strengthening the synthesis of collagen and reducing the release of proinflammatory cytokines and metalloproteinases. The Applicant has surprisingly observed that the cell activity thus stimulated repairs the skin and its wrinkles and increases its elasticity, while at the same time, light activates the natural production processes of the various components of the skin, in particular stimulating the activity of fibroblasts, increasing the production of collagen and fibers, thus also having an anti-aging and anti-wrinkle effect that promotes healing, cell regeneration and angiogenesis.

[0015] A first object of the invention is a method for the cosmetic treatment of an area of ​​skin comprising the following successive steps:

[0016] - applying to said skin area a cosmetic composition comprising at least one photoactive extract of microalgae;

[0017] - irradiating the skin area to which the composition has been applied with a light source emitting light at a wavelength of 400 to 750 nm.

[0018] According to the present invention, microalgae means unicellular chlorophyll photoautotrophic organisms. These organisms include eukaryotic microalgae, characterized by a cell wall and a nucleus, specifically comprising green algae (chlorophytes), golden algae (chrysophytes), dinoflagellates (pyrrophytes), coccolithophytes (coccolithophytes), diatoms (diatoms), euglenophytes (euglenophytes), red algae (rhodophytes) and trebouxiophytes (trebouxiophytes), as well as prokaryotes also known as "cyanobacteria", which do not have a nucleus or a cell wall; and include cyanobacteria.

[0019] According to the present invention, the at least one microalgae is preferably a photoactive microalgae.

[0020] According to the present invention, an extract or photoactive microalgae means that upon illumination (preferably red light), it triggers an oxidative reaction with a ROS production at least 50% higher than the ROS production when the extract is not illuminated, preferably 100% higher ROS production, and increases nitric oxide in a dose-dependent manner, thereby enhancing collagen synthesis and reducing the release of proinflammatory cytokines and metalloproteinases. According to the present invention, the term "photoreactive" can be used instead of the term "photoactive".

[0021] A light source is a device that emits light.

[0022] According to the present invention, the extract of the microalgae is preferably derived from Tetraselmissuecica, Dunaliella salina, Rhodomonas salina, Rhodella maculata, Haematochococcus pluvialis, Porphyridium cruentum, Cyanophora paradoxa, Cylindrotheca clogosterium, Diacronema lutheri, Selenastrum capricornutum, Synechococus sp., Isochrysis sp., Tisochrysis lutea, Phaeodactylum tricornutum, Arthrospira platensis, Stichococcus bacillaris, Xanthonema sp., Nostoc sp., Pseudanaba enagaleata, Chaetoceros calcitrans, Dunaliella Tertiolecta, Chlamydomonas reinhardtii, Tetraselmi stetradithele and / or Porphyridium purpureum.

[0023] Tetraspermum swedishum is a green halophilic microalgae belonging to the class Chlorodendrophytes.

[0024] Dunaliella salina is a green halophilic microalgae belonging to the class Chlorophytes that can grow spontaneously, preferably in a very saline lagoon environment.

[0025] Saltwater cryptoalgae, formerly known as Pyrenomonas salina, is a species of algae in the family Cryptophyta that is found in all aquatic environments and primarily serves as food for copepods.

[0026] Rhodella violacea is a unicellular red algae of the family Rhodellaceae.

[0027] Haematococcus pluvialis is a species of freshwater unicellular green algae in the family Haematococcaceae.

[0028] Blood algae is a species of red algae in the unicellular algae family (Porphyridiophyceae).

[0029] Cyanobacteria are a type of algae in the family Glaucocystaceae.

[0030] Cylindrotheca closterium is a marine diatom that lives in intertidal environments.

[0031] Pavlova is a haptophyte used in aquaculture as food for marine invertebrates, especially bivalves.

[0032] Raphidocelis subcapitata is a microalgae that is often used as a bioindicator of nutrient levels of toxic substances in freshwater because it is very sensitive to the presence of toxic substances such as metals.

[0033] Synechococcus is a species of single-celled cyanobacteria that lives primarily in marine environments.

[0034] Isochrysis is a unicellular algae that contains large amounts of fucoxanthin.

[0035] Chrysophyte Tahitiana is a type of haptophyte that is often used as food in aquaculture.

[0036] Phaedodactylum tricornutum is a species of marine diatom, especially cultivated for use as food for mollusks and fish.

[0037] Arthrospira platensis is a species of the Phormidiaceae family.

[0038] Schizothrix baculata is a terrestrial algae found especially on the ground, stone walls, tiles, tree trunks, glass, and wet banks.

[0039] Heteronema is a type of brown algae.

[0040] Nostoc is a species of cyanobacteria in the family Nostocaceae.

[0041] Dunaliella terrestris is a green microalgae that can accumulate lipids under certain conditions.

[0042] Anabaena is a photosynthetic bacterium of the class Cyanobacteria.

[0043] Chaetoceros is a species of diatom in the family Chaetocerotaceae.

[0044] Chlamydomonas reinhardtii, commonly known as green yeast, is a species of green algae.

[0045] Tetrascelis quadripodii is a green algae that contains a large amount of antioxidants.

[0046] Porphyridium cruentum, also known as blood algae (Porphyridium cruentum), is a type of red algae in the unicellular algae family.

[0047] Particularly preferably, according to the present invention, the microalgae extract is an extract of Dunaliella salina.

[0048] Particularly preferably, according to the present invention, the microalgae extract is an extract of Tetraspermum swedishensis.

[0049] Particularly preferably, according to the present invention, the extract of microalgae is an extract of Dunaliella salina and an extract of Tetraspermum swedishensis.

[0050] According to the invention, the extract is preferably a liquid extract of microalgae, preferably obtained after cultivation of the microalgae, centrifugation and grinding of the filter cake. These extracts may be water-soluble and / or fat-soluble.

[0051] Even more preferably, according to the invention, these extracts are water-soluble.

[0052] According to the present invention, the cosmetic composition comprising the Dunaliella salina extract preferably comprises:

[0053] - an extract of Dunaliella salina, representing 0.0001% to 80% by weight of the composition, preferably 0.0001% to 50% by weight of the composition;

[0054] -QSP 100 water;

[0055] - glycerol, 2.50% by weight of the composition;

[0056] - triethanolamine, 0.40% by weight of the composition;

[0057] - ethanol, 15% by weight of the composition;

[0058] - Coconut caprylate and caprate, 1% by weight of the composition;

[0059] - isopropyl myristate, 1% by weight of the composition;

[0060] - Perfume, 0.1% by weight of the composition.

[0061] According to the present invention, the cosmetic composition comprising an extract of Tetraspermum swedishensis preferably comprises:

[0062] - an extract of Tetraspermum swedishum in an amount of 0.0001% to 78% by weight of the composition, preferably 0.0001% to 50% by weight of the composition;

[0063] -QSP 100 water;

[0064] - sweet almond oil, 7.00% by weight of the composition;

[0065] - C12-15 alkyl benzoate, 4.50% by weight of the composition;

[0066] - stearyl alcohol polyether, accounting for 5.65% by weight of the composition;

[0067] - Glyceryl stearate, 1.90% by weight of the composition;

[0068] - dimethicone, 1.40% by weight of the composition;

[0069] - Carbomer, 0.25% by weight of the composition;

[0070] - sodium benzoate, 0.25% by weight of the composition;

[0071] - perfume, 0.20% by weight of the composition;

[0072] - sodium benzoate, 0.18% by weight of the composition;

[0073] - EDTA, 0.10% by weight of the composition.

[0074] According to the present invention, the cosmetic composition comprising an extract of Dunaliella salina and an extract of Tetraspermum swedishensis preferably comprises:

[0075] - an extract of Tetraspermum swedishum in an amount of 0.0001% to 76% by weight of the composition, preferably 0.0001% to 50% by weight of the composition;

[0076] - an extract of Dunaliella salina, representing from 0.0001% to 76% by weight of the composition, preferably from 0.0001% to 50% by weight of the composition;

[0077] -QSP 100 water;

[0078] - cottonseed oil, 4.00% by weight of the composition;

[0079] - glycerol, 3.2% by weight of the composition;

[0080] - sunflower oil, 4.00% by weight of the composition;

[0081] - octyldodecanol, 3.00% by weight of the composition;

[0082] - propylene glycol, 3.70% by weight of the composition;

[0083] - sodium acrylate copolymer, 1.5% by weight of the composition;

[0084] - Caprylic / capric triglyceride, 1.10% by weight of the composition;

[0085] - pentanediol, 0.8% by weight of the composition;

[0086] - Aluminium starch octenylsuccinate, 0.8% by weight of the composition;

[0087] - benzyl alcohol, 0.70% by weight of the composition;

[0088] - lecithin, 0.50% by weight of the composition;

[0089] - Coco-caprylate / caprate, 0.20% by weight of the composition;

[0090] - tocopherol, 0.20% by weight of the composition;

[0091] - EDTA, 0.08% by weight of the composition;

[0092] - Dehydroacetic acid, 0.06% by weight of the composition.

[0093] According to the present invention, the light is preferably red light, the wavelength of the red light is 625 to 670 nm, preferably 645 nm, and the intensity of the red light is 140 to 180 μmol.s -1 .m -2 photons, preferably 155 to 170 μmol.s -1 .m -2 Photon.

[0094] According to the invention, the illumination is preferably achieved using electroluminescent diodes, lasers and / or intense pulsed light.

[0095] According to the invention, intense pulsed light or IPL, also called flash lamp, is understood to be a technology comprising a polychromatic lamp with a high intensity discharge function and filled with a rare gas, such as xenon. The function of the polychromatic lamp is to convert the stored electrical energy into an intense burst of radiant energy. The emitted light covers the ultraviolet, visible and infrared spectral regions, i.e. from 350nm to 1200nm, including red light with a wavelength of 625 to 670nm, preferably 645nm.

[0096] According to the present invention, an electroluminescent diode means an electronic component that emits low-frequency light when an electric current passes through it. It emits a light that is considered to be "cold" because no heat is generated. The emission spectrum of the electroluminescent diode ranges from visible light to infrared light.

[0097] According to the present invention, the electroluminescent diode preferably emits red light with a wavelength of 625 to 670 nm, preferably 645 nm.

[0098] According to the preceding claims, the illumination time is preferably from 1 second to 60 minutes, preferably from 30 seconds to 40 minutes, even more preferably from 10 to 20 minutes.

[0099] According to the present invention, the exposure time means the time during which the skin of an individual is exposed to the light.

[0100] According to the invention, the light source is preferably placed at a distance of 2 mm to 10 cm from the skin area to be treated.

[0101] According to the present invention, the light source preferably provides a light intensity between 3 and 150 J / cm 2 between.

[0102] According to a second aspect, the invention relates to a lighting device for performing a cosmetic treatment according to the method of the invention, the device consisting of a housing containing a light source, the light emission wavelength of which is 400 to 750 nm, preferably 625 to 670 nm, and the intensity of which is 140 to 180 μmol.s -1 .m -2 photons, preferably 155 to 170 μmol.s -1 .m -2 Photon.

[0103] According to the present invention, the light emission wavelength of the light source is preferably 645 nm.

[0104] According to the present invention, the light source preferably comprises at least one LED having a light emission wavelength spectrum of 400 to 750 nm, preferably 625 to 670 nm, and an intensity of 140 to 180 μmol.s -1 .m -2 photons, preferably 155 to 170 μmol.s -1 .m -2 Photon.

[0105] According to the present invention, the light emission wavelength of the at least one LED is preferably 645 nm.

[0106] According to the present invention, the light source preferably exhibits a 0.15 cm 2 Up to 2900cm 2 surface area.

[0107] According to one embodiment of the present invention, the light source preferably exhibits a wavelength of 0.25 to 1450 cm 2 surface area.

[0108] According to the present invention, the device preferably takes the form of a mask, a panel or a manual device.

[0109] According to the present invention, a mask is understood to mean a device capable of subjecting all or part of the face to light. The light source may present a surface area of ​​approximately the surface area of ​​the face, i.e. approximately 500 cm 2 .

[0110] According to the present invention, a manually used device means a handheld device that can expose the skin of an individual to light in a localized manner. For example, the manual device can be a pen, and the light source can then present a localized area of ​​about 0.15 to 2 cm 2 or the hand-held device is an electric shaver-sized device, and then the light source may exhibit a surface area of ​​about 2 to 7 cm 2 Surface area.

[0111] According to the invention, a panel is understood to mean a device that allows a large part of an individual's body to be illuminated. This type of device can even allow the entire individual's body to be illuminated. The light source can then exhibit a 550 cm 2 Up to 1500cm 2 surface area.

[0112] According to a third aspect, the present invention relates to a kit comprising:

[0113] - a cosmetic composition comprising at least one photoactive extract of microalgae;

[0114] - A lighting device for performing a cosmetic treatment according to the invention.

[0115] According to the present invention, the extract of microalgae is preferably selected from the following extracts: Swedish dinoflagellates, Dunaliella salina, saltwater cryptomonads, rose algae, Haematococcus pluvialis, blood algae, blue algae, crescent columnar algae, Pavlova, Capricornis, Synechococcus, Isochrysis, Tahitian Chrysophyte, Triangular finger algae, Platensis, Rod-shaped diatoms, Alisma, Nostoc, Anabaena, calcareous horned algae, Dunaliella, Chlamydomonas reinhardtii, Tetrascelis quadrilateral and / or Porphyridium.

[0116] According to the present invention, the composition preferably comprises an extract of Tetraspermum swedishum.

[0117] According to the present invention, the composition preferably comprises an extract of Dunaliella salina.

[0118] According to the present invention, the light emission wavelength of the lighting device is preferably 400 to 750 nm, and the intensity is 140 to 180 μmol.s -1 .m -2 photons, preferably 155 to 170 μmol.s -1 .m -2 Photon.

[0119] According to the present invention, the light is preferably red light with a wavelength of 625 to 670 nm, preferably 645 nm.

[0120] According to a fourth aspect, the present invention relates to the use of a device according to the invention for an anti-aging and / or anti-wrinkle treatment and / or a treatment to promote the healing of a skin area. BRIEF DESCRIPTION OF THE DRAWINGS

[0121] Figure 1 : ROS production of various photoactive extracts of microalgae after irradiation (645 nm) for 25 min (grey), with a dilution factor of 500. The results of the extracts stored in the dark are shown in black.

[0122] Figure 2 : The effect of light duration on the production of oxidative molecules (ROS) depends on the extract. Extracts from Dunaliella salina (DS) ( Figure 2 A) Extract from Swedish Tetrastigma (TS) Figure 2 B) and extracts from Cryptophyta salina (RS) ( Figure 2 C) Store in dark conditions (i), or irradiate at 645 nm for 1 min (ii), 10 min (iii), or continuously (iv).

[0123] Figure 3 : Genes evaluated during the effectiveness of studying skin cell mRNA expression by microfluidic RT-qPCR.

[0124] Figure 4 :Red LED module (wavelength = 645nm), preset to 160μmol / m 2 / s, for photoactivation (Example 5).

[0125] Examples

[0126] Example 1: Sample preparation

[0127] Characterization of the production of oxidative molecules in microalgae extracts:

[0128] Extracts of the following algae were selected to characterize the increase in their production of oxidative molecules when stimulated by light: Dunaliella salina (DS), Dunaliella tertiolecta (TD), Tetrastigemum swedense (TS), Chlamydomonas reinhardtii (CR), Haematococus pluvialis (HP), Tetrastigemum quadrangularis (TT), Cryptomonas saline (RS), Porphyridium cruentum (PP), and Rosa rugosa (RM).

[0129] To achieve this, the algae were placed in 200 ml culture. After cell counting at 680 nm, 100 to 150 ml of the solution containing the algae were centrifuged at 12,000 rpm for 10 minutes.

[0130] The filter cake was then ground and the ground material was adjusted to 5.0.10 in 150 ml PBS. 5 cells / ml.

[0131] After cell counting at 680 nm, the conditioned ground material was then centrifuged at 12,000 rpm for 10 minutes.

[0132] Finally, the supernatant was filtered at 0.2 μm to obtain samples for analysis.

[0133] Once ready for analysis, samples consisting of these algae extracts were placed under the following conditions:

[0134] 1. Protect from light, add 15 μl of reaction medium to 30 ml of supernatant filtered at 0.2 μm;

[0135] 2. Protect from light, add 15 μl of reaction medium to 30 ml of supernatant filtered at 0.2 μm, and then continuously illuminate at 645 nm with an intensity of 166 μmol.s -1 .m -2 .

[0136] 3. Protect from light, take 30 ml of the supernatant filtered with 0.2 μm, bubble with dinitrogen for 30 minutes, and then mix with 15 μl of reaction medium. Then, at 645 nm, the concentration of 166 μmol.s -1 .m-2 The illumination step is performed with an intensity of .

[0137] Example 2: Strain screening

[0138] The various extracts were then studied by fluorescence analysis using a spectrofluorometer, either keeping them in the dark or irradiating them at 645 nm for 25 minutes with a dilution factor of 500. The parameters were as follows:

[0139] Excitation light: 500 Emission light: 522

[0140] Excitation light: Scanning range 495–505

[0141] Emitted light: Scan range 400–650

[0142] The results are as follows Figure 1 shown.

[0143] These results indicate that for all the extracts studied, ROS production increased after illumination.

[0144] Specifically, the ROS production of DS extract increased by 5 times, that of TD extract increased by 5.5 times, that of TS extract increased by 3.6 times, that of CR extract increased by 2.1 times, that of PP extract increased by 2 times, that of RS extract increased by 6.8 times, that of RM extract increased by 2.3 times, that of HP extract increased by 3.1 times, and that of TT extract increased by 3.4 times.

[0145] Example 3: The influence of light duration:

[0146] The extracts were then studied based on the duration of light exposure. The 4 phases of the study were:

[0147] -Extracts stored away from light

[0148] -Extracts irradiated at 645 nm for 1 min

[0149] -Extracts irradiated at 645 nm for 10 min

[0150] -Extracts were continuously illuminated at 645 nm.

[0151] DS( Figure 2 A) TS( Figure 2 B) and RS( Figure 2 C) The result is as follows Figure 2 shown.

[0152] These results indicate that ROS production was constant under light-protected conditions, regardless of the microalgae extract.

[0153] For the 1 minute illumination condition, the extracts of DS, TS and RS all showed an increase in ROS production, which disappeared after about 20 / 25 minutes. The production increased, reached a maximum at about 20 / 25 minutes, and then decreased. Thus, an increase of up to about 2.5 times was observed for DS, up to 5 times for TS, and up to about 3 times for RS.

[0154] After that, for the case of 10 minutes of light exposure, the extracts of DS, TS and RS all showed an increase in ROS production, which was greater than the characteristic after 1 minute of light exposure. The production increased, reached a maximum at about 25 / 30 minutes, and then decreased. Thus, compared with the case of the absence of light, an increase of up to about 4.5 times was observed for DS, up to 7 times for TS, and up to 5 times for RS was observed.

[0155] In the case of continuous illumination, a curve close to that after 10 minutes of illumination was observed. Thus, the production increased, reached a maximum at about 25 / 30 minutes, and then decreased. For DS, the maximum production was observed after 25 minutes, which was 3.5 times the production under the dark condition, and thus slightly lower than 10 minutes of illumination. In the first 25 minutes, the gradual increase in ROS production was similar to the characteristics of 10 minutes of illumination. However, after 35 minutes, continuous illumination seemed to produce more ROS than after 10 minutes of illumination. For TS, the maximum production was observed after 30 minutes, which was 6 times the production under the dark condition, and thus slightly lower than the case of 10 minutes of illumination. In the first 25 minutes, the gradual increase in ROS production was similar to the characteristics of 10 minutes of illumination. However, after 35 minutes, continuous illumination seemed to produce more ROS than after 10 minutes of illumination. For RS, the maximum production was observed after 25 minutes, which was 5 times the production under the dark condition, and thus the same as 10 minutes of illumination. However, after 35 min, continuous illumination appeared to show sustained ROS production, which was greater than that after 10 min of illumination.

[0156] In summary, there was no continuous increase in the response, so that the maximum ROS production in each strain reached a specific plateau, which was reached at about 25 / 30 minutes with a light rate of 10 minutes. In addition, it can be clearly seen that the end of production depends on the light duration, with the 1 and 10 minute light conditions showing a decrease in ROS production after 20 to 30 minutes.

[0157] Example 4: Clinical evaluation of 30 anti-aging beauty care subjects using a device with a light emission wavelength of 645 nm estimate Overall, the clinical studies involved 30 women between the ages of 35 and 70.

[0158] a) A cosmetic composition was applied and irradiated with light of 645 nm.

[0159] A clinical dermatological examination of skin tone (analysis by touch) and fine lines or wrinkles (semi-quantitative scoring) was performed. Macro photographs were taken (subjects without makeup, standard pose). The surface area, depth and skin roughness of wrinkles were measured at D0 and D28 using a measuring instrument (SkinStation).

[0160] Apply 0.4 g of the composition to the face.

[0161] The skin area containing crow's feet is illuminated by an illumination device emitting light at a wavelength of 625 to 670 nm.

[0162] Apply a 645nm light source (duration, distance, intensity).

[0163] c) Conclusion

[0164] After treatment with the composition and device, clinical improvement of the skin was observed in 27 of the 30 subjects.

[0165] The product is extremely well tolerated and, overall, the cosmetic assessment is very good.

[0166] Therefore, the cosmetic care method according to the present invention can significantly reduce skin wrinkles.

[0167] Example 5: Effectiveness of evaluating skin cell mRNA expression by microfluidics RT-qPCR after application of light-activated extracts.

[0168] The entire process was carried out in semi-darkness.

[0169] Material:

[0170] - Red LED module (wavelength = 645nm), preset to 160μmol / m 2 / s, such as Figure 4 shown.

[0171] -20ml glass test tube

[0172] -Fixture

[0173] -Stand with rod included

[0174] plan:

[0175] In semi-darkness, pour 5 ml of the extract into a test tube.

[0176] The tube is then fixed to the rod of the support by means of a clamp and the tube is placed in the center of the module of LEDs.

[0177] Then light up the red LED module and let the light shine continuously for 10 minutes.

[0178] After 10 minutes, the light was switched off and the sample was kept in semi-darkness.

[0179] Remove the extract from the test tube using a pipette without stirring.

[0180] In the rest of the protocol, the photoactivated extracts were used in the fresh state.

[0181] The experiments were performed in triplicate (n=3) on normal human epidermal keratinocytes (NHEK) and normal human dermal fibroblasts (NHDF) using the extracts activated as described above.

[0182] Analytical methods:

[0183] mRNA is extracted and reverse transcribed into cDNA. Quantification of gene expression is performed using qPCR and normalized by the expression of reference genes. To confirm the effect of activators or inhibitors, these values ​​are compared to reference conditions after exposure to the extracts.

[0184] The genes evaluated were Figure 3 shown.

[0185] Increased expression of claudin 1, collagen, fibrillin 1, and fibrillin 2 genes, as well as general antioxidant genes, was observed. At the same time, decreased expression of metallopeptidase 1, 3, and 9 genes and inflammation were observed.

[0186] In conclusion, a reduction in the expression of genes that promote skin aging was observed.

Claims

1. A method for the cosmetic non-therapeutic care of a skin area comprising the following consecutive steps: - applying to said skin area a cosmetic composition comprising at least one photoactive extract of microalgae chosen from Tetraselmis suecica and / or Dunaliella salina; - irradiating the skin area to which the composition has been applied with red light having a wavelength of 625 to 670 nm and an intensity of 140 to 180 μmol.s -1 .m -2 Photon.

2. The cosmetic non-therapeutic care method according to claim 1, wherein the wavelength of the red light is 645 nm.

3. The cosmetic non-therapeutic care method according to claim 1, wherein the intensity of the red light is 155 to 170 μmol.s -1 .m -2 Photon.

4. A cosmetic non-therapeutic treatment method according to claim 1, wherein the illumination is achieved using electroluminescent diodes, lasers and / or intense pulsed light.

5. The cosmetic non-therapeutic care method according to any one of claims 1 to 4, wherein the light exposure time is from 1 second to 60 minutes.

6. The cosmetic non-therapeutic care method according to claim 5, wherein the light exposure time is 30 seconds to 40 minutes.

7. The cosmetic non-therapeutic care method according to any one of claims 1 to 4, wherein the cosmetic composition comprises an extract of Dunaliella salina, comprising: - Dunaliella salina extract, representing 0.0001% to 80% by weight of the composition; - QSP 100 water; - glycerol, 2.50% by weight of the composition; - triethanolamine, 0.40% by weight of the composition; - ethanol, 15% by weight of the composition; - Coco-caprylate-caprate, 1% by weight of the composition; - isopropyl myristate, 1% by weight of the composition; - Perfume, 0.1% by weight of the composition.

8. The cosmetic non-therapeutic care method of claim 7, wherein the cosmetic composition comprising the Dunaliella salina extract comprises from 0.0001% to 50% of the Dunaliella salina extract by weight of the composition.

9. The cosmetic non-therapeutic care method according to any one of the preceding claims 1 to 4, wherein the cosmetic composition comprises a Tetraspermum swedish extract comprising: - Tetraspermum swedishum extract in an amount ranging from 0.0001% to 78% by weight of the composition; - QSP 100 water; - sweet almond oil, 7.00% by weight of the composition; - C12-15 alkyl benzoate, 4.50% by weight of the composition; - Stearyl alcohol polyether, 5.65% by weight of the composition; - Glyceryl stearate, 1.90% by weight of the composition; - dimethicone, 1.40% by weight of the composition; - Carbomer, 0.25% by weight of the composition; - sodium benzoate, 0.25% by weight of the composition; - perfume, 0.20% by weight of the composition; - sodium benzoate, 0.18% by weight of the composition; - EDTA, 0.10% by weight of the composition.

10. The cosmetic non-therapeutic care method according to claim 9, wherein the cosmetic composition comprising the Tetraselena swedish extract comprises 0.0001% to 50% of the Tetraselena swedish extract by weight of the composition.

11. The cosmetic non-therapeutic care method according to any one of claims 1 to 4, wherein the cosmetic composition comprises an extract of Dunaliella salina and an extract of Tetraselena swedisha, comprising: - Tetraspermum swedishum extract in an amount ranging from 0.0001% to 76% by weight of the composition; - Dunaliella salina extract, representing 0.0001% to 76% by weight of the composition; - QSP 100 water; - cottonseed oil, 4.00% by weight of the composition; - glycerol, 3.2% by weight of the composition; - sunflower oil, 4.00% by weight of the composition; - Octyldodecanol, 3.00% by weight of the composition; - propylene glycol, 3.70% by weight of the composition; - sodium acrylate copolymer, 1.5% by weight of the composition; - Caprylic / capric triglyceride, 1.10% by weight of the composition; - pentanediol, 0.8% by weight of the composition; - Aluminium starch octenylsuccinate, 0.8% by weight of the composition; - benzyl alcohol, 0.70% by weight of the composition; - lecithin, 0.50% by weight of the composition; - Coco-caprylate / caprate, 0.20% by weight of the composition; - tocopherol, 0.20% by weight of the composition; - EDTA, 0.08% by weight of the composition; - Dehydroacetic acid, 0.06% by weight of the composition.

12. The cosmetic non-therapeutic care method according to claim 11, wherein the cosmetic composition comprising Dunaliella salina extract and Tetraspermum swedish extract comprises 0.0001% to 50% Tetraspermum swedish extract by weight of the composition.

13. The cosmetic non-therapeutic care method of claim 11, wherein the cosmetic composition comprising Dunaliella salina extract and Tetraspermum swedish extract comprises 0.0001% to 50% of Dunaliella salina extract by weight of the composition.

14. A lighting device for performing non-therapeutic cosmetic treatments according to any one of claims 1 to 4, the device comprising a housing containing a light source, wherein the light emitted by the light source has a wavelength spectrum of 625 to 670 nm and a light intensity of 140 to 180 μmol.s -1 .m -2 Photon.

15. The lighting device according to claim 14, wherein the light intensity emitted by the light source is 155 to 170 μmol.s -1 .m -2 Photon.

16. Use of the device according to claim 14 for anti-aging and / or anti-wrinkle non-therapeutic care and / or non-therapeutic care to promote healing of said skin area.

17. A skin care kit comprising: - a cosmetic composition comprising at least one photoactive extract of microalgae chosen from Tetraspermum sutchuenensis and / or Dunaliella salina; - A lighting device according to claim 14.